Related references
Note: Only part of the references are listed.Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies
Christopher B. Cole et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Next-generation sequencing identifies major DNA methylation changes during progression of Ph plus chronic myeloid leukemia
G. Heller et al.
LEUKEMIA (2016)
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas
Dong Fang et al.
SCIENCE (2016)
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
Thomas E. Bartlett et al.
NATURE COMMUNICATIONS (2016)
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma
Michael R. Green et al.
NATURE COMMUNICATIONS (2014)
Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations
Jonathan M. Gerber et al.
ONCOTARGET (2013)
A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors
Carolina Vicente-Duenas et al.
EMBO JOURNAL (2012)
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
Amie S. Corbin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cancer induction by restriction of oncogene expression to the stem cell compartment
Maria Perez-Caro et al.
EMBO JOURNAL (2009)
Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice
G. Howard et al.
ONCOGENE (2008)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Induction of tumors in mice by genomic hypomethylation
F Gaudet et al.
SCIENCE (2003)
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia
S Mizuno et al.
BLOOD (2001)
Share Paper
